Abstract 2064P
Background
Hospitalisation is an inevitable step in the evolution of many patients with cancer, principally in advanced tumors. This study aims to describe the admissions to a medical oncology inpatient service of our University Hospital between November 2022 and April 2023.
Methods
We conducted a retrospective cross-sectional study of patients admitted to the Medical Oncology Service of Infanta Sofía University Hospital (Madrid) along six months. Database was collected from the electronic health records. The following variables were analyzed: age, sex, type of tumor, stages, origin of the admission, period of hospital stay, diagnoses, assessment by another specialities, type of discharge and readmissions.
Results
In the chosen period, 310 hospitalisations related to 223 patients were studied, because some of them were readmitted in these six months. The average age was 71.49 years, 42.9% women and 57.1% men. The average hospital stay was 10.18 days. Near 77% of the patients had advanced disease. In order of frequency, patients with lung (28.06%), colorectal (15.8%) and genitourinary (11.94%) cancer represented the most of inpatients. Mainly the patients were admitted from the Emergency Department of our Hospital (56.45%). The most prevalent reason for hospitalisation was secondary symptoms of disease progression. Infections were the cause of admission in 24.52% of the cases and 27.42% of them were from respiratory system. Other causes to take into account were the toxicity to the treatment (5.8%). As part of the multidisciplinary approach, during their hospitalisation, 5.26% inpatients required surgical assessment. Interventional radiologists treated 1.29% patients and endocrinologists providing nutritional support in 10.65% of cases. Furthermore, less than 2% of our patients were admitted to the Intensive Care Unit. Palliative Care Unit assessed 37.74% of the inpatients, which 19.35% were being previously followed-up by them. Unfortunately 15.8% of the admitted patients died. We also observed 26.45% had to be admitted again.
Conclusions
It is important to identify the reasons why patients with cancer are admitted to the Hospital because it could help to identify areas for improvement in the quality of care.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2096P - Morphine titration with intravenous patient-controlled analgesia for severe cancer pain (Mr.TIPS)
Presenter: Seok Jae Huh
Session: Poster session 06
2097P - Incidence, risk factors (RFs) and management of oral mucositis (OM) in patients (pts) treated with a fluoropyrimidines (FP)-based therapy (tp): A retrospective, monocentric experience
Presenter: Fiorella Manfredi
Session: Poster session 06
2098P - The impact of concomitant use of non-opioid analgesics and immune checkpoint inhibitors on survival in lung cancer patients: A Hong Kong population-based cohort study
Presenter: Zheng-Hao Ye
Session: Poster session 06
2099P - The role of ambulatory blood pressure measurement in TKI-induced arterial hypertension diagnosis
Presenter: Elina Khachaturian
Session: Poster session 06
2100P - An exploratory study of the efficacy and safety of hetrombopag in the treatment of thrombocytopenia induced by concurrent or sequential chemoradiotherapy
Presenter: Jun Wang
Session: Poster session 06
2101P - Bleeding Induced by ANtiCAncer drugs (BIANCA) used breast cancer
Presenter: Nicolas Janus
Session: Poster session 06
2102P - Changes in opioid usage after intrathecal morphine pump implantation in patients with terminal cancer (pilot study)
Presenter: Eun Joo Choi
Session: Poster session 06
2103P - Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head & neck (H&N) cancer
Presenter: Daniel Osei-Fofie
Session: Poster session 06
2104P - Prevention of taxane chemotherapy induced nail changes and peripheral neuropathy by application of extremity cooling: A prospective single center study with intrapatient comparison
Presenter: Kristen Johnson
Session: Poster session 06
2105P - Prophylactic role of a postbiotic microbiota-stabilizer on abemaciclib-induced diarrhea in breast cancer patients: A pilot application study
Presenter: Rita De Sanctis
Session: Poster session 06